Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor
- PMID: 17635130
- DOI: 10.1042/BST0350709
Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor
Abstract
The secretin receptor is prototypic of Class II GPCRs (G-protein-coupled receptors), based on its structural and functional characteristics and those of its natural agonist ligand. Secretin represents a linear 27-residue peptide with diffuse pharmacophoric domain. The secretin receptor includes the typical signature sequences for this receptor family within its predicted transmembrane segments and the highly conserved six cysteine residues contributing to three intradomain disulfide bonds within its long N-terminus. This domain is critical for secretin binding based on receptor mutagenesis and photoaffinity labelling studies. Full agonist analogues of secretin incorporating a photolabile moiety at various positions throughout the pharmacophore covalently label residues within this region, while only N-terminal probes have labelled the core helical bundle domain. Combining insights coming from receptor structural studies, peptide structure-activity relationship considerations, photoaffinity labelling, and application of fluorescence techniques has resulted in the development of a working model of the secretin-receptor complex. This supports the initial docking of the peptide agonist within a cleft in the receptor N-terminus, providing the opportunity for an endogenous sequence within that domain to interact with the core of the receptor. This interaction is believed to be key in the molecular basis of conformational change associated with activation of this receptor. The site of action of this endogenous agonist could also provide a possible target for small molecule agonists to act.
Similar articles
-
Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.Ann N Y Acad Sci. 2006 Jul;1070:243-7. doi: 10.1196/annals.1317.022. Ann N Y Acad Sci. 2006. PMID: 16888174
-
Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.Ann N Y Acad Sci. 2006 Jul;1070:248-64. doi: 10.1196/annals.1317.023. Ann N Y Acad Sci. 2006. PMID: 16888175
-
Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.J Pharmacol Exp Ther. 2000 Nov;295(2):682-8. J Pharmacol Exp Ther. 2000. PMID: 11046106
-
The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor.Biochem Soc Trans. 2013 Feb 1;41(1):154-8. doi: 10.1042/BST20120204. Biochem Soc Trans. 2013. PMID: 23356276 Review.
-
Focus on the splicing of secretin GPCRs transmembrane-domain 7.Trends Biochem Sci. 2009 Sep;34(9):443-52. doi: 10.1016/j.tibs.2009.06.002. Epub 2009 Sep 3. Trends Biochem Sci. 2009. PMID: 19733082 Review.
Cited by
-
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.J Biol Chem. 2010 Jan 1;285(1):723-30. doi: 10.1074/jbc.M109.033829. Epub 2009 Oct 27. J Biol Chem. 2010. PMID: 19861722 Free PMC article.
-
Receptor oligomerization: from early evidence to current understanding in class B GPCRs.Front Endocrinol (Lausanne). 2013 Jan 4;3:175. doi: 10.3389/fendo.2012.00175. eCollection 2012. Front Endocrinol (Lausanne). 2013. PMID: 23316183 Free PMC article.
-
Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus.BMC Bioinformatics. 2014;15 Suppl 16(Suppl 16):S13. doi: 10.1186/1471-2105-15-S16-S13. Epub 2014 Dec 8. BMC Bioinformatics. 2014. PMID: 25521597 Free PMC article.
-
Molecular basis of peptide activation of the GLP-1 receptor.Mol Metab. 2013 Mar 6;2(2):60-1. doi: 10.1016/j.molmet.2013.02.003. eCollection 2013. Mol Metab. 2013. PMID: 24199149 Free PMC article. No abstract available.
-
Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor.Br J Pharmacol. 2012 May;166(1):18-26. doi: 10.1111/j.1476-5381.2011.01463.x. Br J Pharmacol. 2012. PMID: 21542831 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources